400 related articles for article (PubMed ID: 19800296)
1. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
[TBL] [Abstract][Full Text] [Related]
2. Decision making in primary sacral tumors.
Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of sacral chordomas combined with transcatheter arterial embolization.
Yang H; Zhu L; Ebraheim NA; Liu J; Shapiro A; Castillo S; Liu X; Tang T
J Spinal Disord Tech; 2010 Feb; 23(1):47-52. PubMed ID: 20084025
[TBL] [Abstract][Full Text] [Related]
4. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
[TBL] [Abstract][Full Text] [Related]
5. Chordoma of the mobile spine: fifty years of experience.
Boriani S; Bandiera S; Biagini R; Bacchini P; Boriani L; Cappuccio M; Chevalley F; Gasbarrini A; Picci P; Weinstein JN
Spine (Phila Pa 1976); 2006 Feb; 31(4):493-503. PubMed ID: 16481964
[TBL] [Abstract][Full Text] [Related]
6. [Sacral chordoma: retrospective review of 11 surgically treated cases].
Jeanrot C; Vinh TS; Anract P; De Pinieux G; Ouaknine M; Forest M; Tomeno B
Rev Chir Orthop Reparatrice Appar Mot; 2000 Nov; 86(7):684-93. PubMed ID: 11104990
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative transarterial embolization for treatment of primary sacral tumors.
Yang HL; Chen KW; Wang GL; Lu J; Ji YM; Liu JY; Wu GZ; Gu Y; Sun ZY
J Clin Neurosci; 2010 Oct; 17(10):1280-5. PubMed ID: 20627583
[TBL] [Abstract][Full Text] [Related]
8. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
[TBL] [Abstract][Full Text] [Related]
10. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
[TBL] [Abstract][Full Text] [Related]
11. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor.
Park L; Delaney TF; Liebsch NJ; Hornicek FJ; Goldberg S; Mankin H; Rosenberg AE; Rosenthal DI; Suit HD
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1514-21. PubMed ID: 16757128
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors for recurrence of giant cell tumor of the sacrum and mobile spine combined with preoperative embolization.
Ming Z; Kangwu C; Huilin Y; Genlin W; Jian L; Yiming J; Chunshen W; Chao C
Turk Neurosurg; 2013; 23(5):645-52. PubMed ID: 24101313
[TBL] [Abstract][Full Text] [Related]
14. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
[TBL] [Abstract][Full Text] [Related]
15. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.
Chen KW; Yang HL; Lu J; Wang GL; Ji YM; Wu GZ; Zhu LF; Liu JY; Chen XQ; Gu YP
J Neurooncol; 2011 Feb; 101(3):357-63. PubMed ID: 20549300
[TBL] [Abstract][Full Text] [Related]
17. [Our experience with chordoma treatment].
Brindza P; Chaloupka R; Grosman R
Acta Chir Orthop Traumatol Cech; 2009 Oct; 76(5):382-7. PubMed ID: 19912701
[TBL] [Abstract][Full Text] [Related]
18. Sacrectomy and adjuvant radiotherapy for the treatment of sacral chordomas: a single-center experience over 27 years.
Dhawale AA; Gjolaj JP; Holmes L; Sands LR; Temple HT; Eismont FJ
Spine (Phila Pa 1976); 2014 Mar; 39(5):E353-9. PubMed ID: 24365895
[TBL] [Abstract][Full Text] [Related]
19. Challenges of local recurrence and cure in low grade malignant tumors of the spine.
Boriani S; Saravanja D; Yamada Y; Varga PP; Biagini R; Fisher CG
Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S48-57. PubMed ID: 19829277
[TBL] [Abstract][Full Text] [Related]
20. Primary tumors of the cervical spine: a retrospective review of 35 surgically managed cases.
Zileli M; Kilinçer C; Ersahin Y; Cagli S
Spine J; 2007; 7(2):165-73. PubMed ID: 17321965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
